56 related articles for article (PubMed ID: 16434323)
1. Genotoxicity of etoposide: greater susceptibility of MLL than other target genes.
Ng A; Taylor GM; Eden OB
Cancer Genet Cytogenet; 2006 Jan; 164(2):164-7. PubMed ID: 16434323
[TBL] [Abstract][Full Text] [Related]
2. Role of apoptotic nuclease caspase-activated DNase in etoposide-induced treatment-related acute myelogenous leukemia.
Hars ES; Lyu YL; Lin CP; Liu LF
Cancer Res; 2006 Sep; 66(18):8975-9. PubMed ID: 16982737
[TBL] [Abstract][Full Text] [Related]
3. Etoposide metabolites enhance DNA topoisomerase II cleavage near leukemia-associated MLL translocation breakpoints.
Lovett BD; Strumberg D; Blair IA; Pang S; Burden DA; Megonigal MD; Rappaport EF; Rebbeck TR; Osheroff N; Pommier YG; Felix CA
Biochemistry; 2001 Feb; 40(5):1159-70. PubMed ID: 11170441
[TBL] [Abstract][Full Text] [Related]
4. Gene rearrangements of MLL and RUNX1 sporadically occur in normal CD34
Harada Y; Shingai N; Ding Y; Sadato D; Hayashi Y; Yamaguchi M; Okuyama Y; Shimoyama T; Ohashi K; Harada H
Cancer Sci; 2020 May; 111(5):1851-1855. PubMed ID: 32216001
[TBL] [Abstract][Full Text] [Related]
5. Repositioning of ETO gene in cells treated with VP-16, an inhibitor of DNA-topoisomerase II.
Rubtsov MA; Terekhov SM; Razin SV; Iarovaia OV
J Cell Biochem; 2008 May; 104(2):692-9. PubMed ID: 18183572
[TBL] [Abstract][Full Text] [Related]
6. The broken MLL gene is frequently located outside the inherent chromosome territory in human lymphoid cells treated with DNA topoisomerase II poison etoposide.
Glukhov SI; Rubtsov MA; Alexeyevsky DA; Alexeevski AV; Razin SV; Iarovaia OV
PLoS One; 2013; 8(9):e75871. PubMed ID: 24086652
[TBL] [Abstract][Full Text] [Related]
7. Mutation E522K in human DNA topoisomerase IIbeta confers resistance to methyl N-(4'-(9-acridinylamino)-phenyl)carbamate hydrochloride and methyl N-(4'-(9-acridinylamino)-3-methoxy-phenyl) methane sulfonamide but hypersensitivity to etoposide.
Leontiou C; Lakey JH; Austin CA
Mol Pharmacol; 2004 Sep; 66(3):430-9. PubMed ID: 15322234
[TBL] [Abstract][Full Text] [Related]
8. In vitro cleavage of the MLL gene by topoisomerase II inhibitor (etoposide) in normal cord and peripheral blood mononuclear cells.
Ishii E; Eguchi M; Eguchi-Ishimae M; Yoshida N; Oda M; Zaitsu M; Fujita I; Miyazaki S; Hamasaki Y; Mizutani S
Int J Hematol; 2002 Jul; 76(1):74-9. PubMed ID: 12138900
[TBL] [Abstract][Full Text] [Related]
9. A three-dimensional quantitative structure-activity relationship study of the inhibition of the ATPase activity and the strand passing catalytic activity of topoisomerase IIalpha by substituted purine analogs.
Jensen LH; Liang H; Shoemaker R; Grauslund M; Sehested M; Hasinoff BB
Mol Pharmacol; 2006 Nov; 70(5):1503-13. PubMed ID: 16880287
[TBL] [Abstract][Full Text] [Related]
10. RUNX1 meets MLL: epigenetic regulation of hematopoiesis by two leukemia genes.
Koh CP; Wang CQ; Ng CE; Ito Y; Araki M; Tergaonkar V; Huang G; Osato M
Leukemia; 2013 Sep; 27(9):1793-802. PubMed ID: 23817177
[TBL] [Abstract][Full Text] [Related]
11. Environmental and chemotherapeutic agents induce breakage at genes involved in leukemia-causing gene rearrangements in human hematopoietic stem/progenitor cells.
Thys RG; Lehman CE; Pierce LC; Wang YH
Mutat Res; 2015 Sep; 779():86-95. PubMed ID: 26163765
[TBL] [Abstract][Full Text] [Related]
12. A three-dimensional quantitative structure-activity analysis of a new class of bisphenol topoisomerase IIalpha inhibitors.
Liang H; Wu X; Yalowich JC; Hasinoff BB
Mol Pharmacol; 2008 Mar; 73(3):686-96. PubMed ID: 18045852
[TBL] [Abstract][Full Text] [Related]
13. NK314, a novel topoisomerase II inhibitor, induces rapid DNA double-strand breaks and exhibits superior antitumor effects against tumors resistant to other topoisomerase II inhibitors.
Onda T; Toyoda E; Miyazaki O; Seno C; Kagaya S; Okamoto K; Nishikawa K
Cancer Lett; 2008 Jan; 259(1):99-110. PubMed ID: 17998154
[TBL] [Abstract][Full Text] [Related]
14. Multistep pathogenesis of leukemia via the MLL-AF4 chimeric gene/Flt3 gene tyrosine kinase domain (TKD) mutation-related enhancement of S100A6 expression.
Yamaguchi H; Hanawa H; Uchida N; Inamai M; Sawaguchi K; Mitamura Y; Shimada T; Dan K; Inokuchi K
Exp Hematol; 2009 Jun; 37(6):701-14. PubMed ID: 19463771
[TBL] [Abstract][Full Text] [Related]
15. Validation of an interphase fluorescence in situ hybridization approach for the detection of MLL gene rearrangements and of the MLL/AF9 fusion in acute myeloid leukemia.
Cavazzini F; Bardi A; Tammiso E; Ciccone M; Russo-Rossi A; Divona D; Lo Coco F; Hernandez JM; Wlodarska I; Hagemeijer A; Castoldi G; Cuneo A
Haematologica; 2006 Mar; 91(3):381-5. PubMed ID: 16503549
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of cooperative gene mutations between class I and class II in de novo acute myeloid leukemia.
Ishikawa Y; Kiyoi H; Tsujimura A; Miyawaki S; Miyazaki Y; Kuriyama K; Tomonaga M; Naoe T
Eur J Haematol; 2009 Aug; 83(2):90-8. PubMed ID: 19309322
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic and molecular analysis of MLL rearrangements in acute lymphoblastic leukaemia survivors.
Brassesco MS; Montaldi AP; Gras DE; Camparoto ML; Martinez-Rossi NM; Scrideli CA; Tone LG; Sakamoto-Hojo ET
Mutagenesis; 2009 Mar; 24(2):153-60. PubMed ID: 19028982
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy-related secondary leukemias: A role for DNA repair by error-prone non-homologous end joining in topoisomerase II - Induced chromosomal rearrangements.
Kantidze OL; Razin SV
Gene; 2007 Apr; 391(1-2):76-9. PubMed ID: 17234368
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of the DNA Damage Response and KMT2A Rearrangement in Fetal Liver Hematopoietic Cells.
Nanya M; Sato M; Tanimoto K; Tozuka M; Mizutani S; Takagi M
PLoS One; 2015; 10(12):e0144540. PubMed ID: 26657054
[TBL] [Abstract][Full Text] [Related]
20. Detection and treatment of molecular relapse in acute myeloid leukemia with RUNX1 (AML1), CBFB, or MLL gene translocations: frequent quantitative monitoring of molecular markers in different compartments and correlation with WT1 gene expression.
Doubek M; Palasek I; Pospisil Z; Borsky M; Klabusay M; Brychtova Y; Jurcek T; Jeziskova I; Krejci M; Dvorakova D; Mayer J
Exp Hematol; 2009 Jun; 37(6):659-72. PubMed ID: 19463768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]